4//SEC Filing
Jones Michael L 4
Accession 0001127602-22-008047
CIK 0000882796other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 5:04 PM ET
Size
7.8 KB
Accession
0001127602-22-008047
Insider Transaction Report
Form 4
Jones Michael L
Exec. Director, Finance - PAO
Transactions
- Exercise/Conversion
Common Stock
2022-03-01$4.73/sh+2,300$10,879→ 13,498 total - Sale
Common Stock
2022-03-01$17.20/sh−2,300$39,560→ 11,198 total - Exercise/Conversion
Emp. Stock Option (Right to Buy)
2022-03-01−2,300→ 0 totalExercise: $4.73From: 2013-03-01Exp: 2022-03-01→ Common Stock (2,300 underlying)
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001800060
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 5:04 PM ET
- Size
- 7.8 KB